Dexmedetomidine for Treatment of Delayed Peak Symptoms of Cannabis Withdrawal Syndrome: A Case Report.
Publication Title
Hospital pharmacy
Document Type
Article
Publication Date
10-1-2021
Keywords
washington; olympia; psph; cannabis; cannabis use disorder; dexmedetomidine; withdrawal
Abstract
Background: Cannabis withdrawal syndrome (CWS) is characterized by irritability, sleep disorders, and physical discomfort that typically peaks within 7 days of cessation. Case: A patient with a 30-year history of heavy cannabis developed prolonged symptoms of CWS that peaked at greater than 40 days after cessation, who was successfully managed with dexmedetomidine. Discussion: This case report documents an unusual case of significantly delayed CWS peak in symptoms, as well as the novel use of dexmedetomidine for inpatient management of CWS.
Specialty/Research Institute
Pharmacy
COinS
